Transport of Potential Manure Hormone and Pharmaceutical Contaminants through Intact Soil Columns.

Although adding manure to agricultural soils is a commonly practiced disposal method and a means to enhance soil productivity, potential environmental contamination by any associated chemicals of emerging concern (CECs) such as hormones and pharmaceuticals is not well understood. Our objective was to provide field-relevant predictions of soil transport and attenuation of 19 potential manure CECs using undisturbed soil columns irrigated under unsaturated conditions. The CEC concentrations in leached water were monitored for 13 wk using high performance liquid chromatography-time of flight-mass spectrometry (HPLC-TOF-MS), after which time soil in the cores was removed and sampled for extractable CECs. Compounds quantified in column leachate included all four of the added sulfonamide antibiotics and the nonsteroidal, anti-inflammatory drug flunixin. Only trace amounts of several of the seven hormones, five remaining antibiotics, and two antimicrobials leached from the columns from exogenous soil additions. Soil residues of all 19 compounds were detected, with highest extractable amounts for 17α-hydroxyprogesterone > triclosan (antimicrobial) > flunixin > oxytetracycline. Those CECs with the highest recoveries as calculated by summing leached and extractable amounts were flunixin (14.5%), 17α-hydroxyprogesterone (5.3%), triclosan (4.6%), and sulfadimethoxine (4.8%). Manure management to prevent CEC contamination should consider the potential environmental problems caused by negatively charged compounds with the greatest mobility (flunixin and sulfadimethoxine) and those that have long residence times in soil (triclosan, 17α-hydroxyprogesterone, flunixin, and oxytetracycline). Flunixin is particularly important given its mobility and long residence time in soil.

Patient engagement in research related to dementia: A scoping review.

Patient 'engagement' or 'involvement' in health research broadly refers to including people with lived experience (i.e. individuals with personal experience of a health issue and their friends, family and caregivers or carers) in the research process. Although previous reviews have systematically summarized approaches to patient engagement in research, it is unclear whether and how engagement activities have been implemented or adapted for research related to dementia. We conducted a scoping review to describe the extent and nature of patient engagement approaches that have been used to involve persons with dementia and their care partners in research. We then summarized the reported barriers, enablers, and impacts of this engagement. Fifty-four research articles were included in the review and almost all were published after 2010. Persons with dementia and their care partners have been engaged in diverse phases of the research process. The majority of engagement involved both persons with dementia and care partners. Barriers and enablers to engagement included those identified for general patient engagement in research, but some more specific to engaging persons with dementia and their care partners were also reported. Very few studies assessed the impact of patient engagement. While the arguments for patient engagement in research are compelling, research to demonstrate the impact - on the research process and outcomes as well as on persons with dementia, care partners, researchers, research institutions and society - is still needed.